Rashid Gabbasov's profile picture

Rashid Gabbasov

Senior Scientist at Carisma Therapeutics

Rashid Gabbasov has been working in the field of pre-clinical drug research since 2010. Rashid began their career as an Undergraduate Researcher at Kazan State Medical University in 2010. Rashid then went on to pursue a Graduate Student role at Kazan Federal University in 2011. In the same year, they took on a Postdoctoral Associate role at Fox Chase Cancer Center, where they gained 2+ years of experience in pre-clinical assessment of molecular mechanisms of single and combined drug action. Rashid'scurrent project focuses on pre-clinical evaluation of combination of PARP and HSP90 inhibitors in order to improve outcomes of BRCA mutation-negative ovarian cancer patients. Rashid also has extensive experience with patient-derived xenografts, handling the full pipeline of establishing PDXs from processing and implantation of patient tumors into mice, to isolation of patient tumor-derived cell lines and recruiting them in pre-clinical drug research. In 2019, they joined Carisma Therapeutics as a Senior Scientist, and has since held Scientist II and Scientist roles.

Rashid Gabbasov completed a Doctor of Philosophy - PhD in Biochemistry from Kazan Federal University in 2016, after completing a BS/MS combined degree program in Genetics from the same university in 2011.

Links

Previous companies

Fox Chase Cancer Center logo

Org chart

This person is not in the org chart



Offices

This person is not in any offices


  1. This content will be removed shortly.